Tecentriq Atezolizumab

Tecentriq Atezolizumab

Tecentriq (Atezolizumab) - Tecentriq (Atezolizumab) is an experimental anticancer immunotherapy agent. The drug was registered in 2016 and received the status of the latest medication designed to combat metastatic bladder tumors. In our online pharmacy you can buy any medicine, including Tecentriq (Atezolizumab) - Tecentriq (Atezolizumab), the cost of which will be much more profitable than on other resources. Indications for use The medicine is prescribed for the treatment of patients diagnosed with locally advanced or metastatic urothelial carcinoma in the following cases: • if the disease progresses during or after treatment with chemotherapy procedures; • if the disease progresses within one year after undergoing neoadjuvant or adjuvant therapy with platinum preparations.

  • Roche

Price: $ 2500

Usefulness

Contraindications There are no contraindications. Side effects Among the undesirable reactions that may occur after taking the drug, the following is noted: • deterioration in appetite; • weakness; • nausea; • lowering the level of hemoglobin; • shortness of breath; • painful sensations in the abdominal region; • pneumonia; • fever; • infectious diseases of the urinary tract. How to store the medicine Ampoules with a solution should be stored in a refrigerator at a temperature of 2-8 ° C. Avoid freezing.

Mechanism of action As shown by the results of clinical trials, during which the effect of the drug Tecentriq (Atezolizumab) was investigated - Tecentriq (Atezolizumab), reviews of oncologists confirmed this - atezolizumab, which is the active substance of the drug, leads to a decrease in the activity of immune cells, which would otherwise have detected and affected tumor cells. The effect of the drug helps to induce the development of an antitumor response. Mode of application The drug Tecentriq (Atezolizumab) - Tecentriq (Atezolizumab) can be purchased in the form of a solution for intravenous infusion. The standard dosage is 1200 mg over one hour. The drug is administered every three weeks. Efficiency At the moment, medical research is being carried out on the drug. According to the information that is available today, the agent reduces the tumor volume of the affected organ.

©2020 CopyRight Onco24.com. All rights reserved.